Company Search:
Advanced Search
Sponsored Links
Geron Corporation Company Snapshot
Geron Corporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Geron with three other companies in this sector in the United States: Chimerix Inc (2016 sales of $5.70 million of which 100% was Pharmaceutical), Apricus Biosciences Inc ($5.76 million ), and Adamis Pharmaceuticals Corp ($6.47 million of which 100% was Pharmaceuticals).

Sales Analysis. Sales fell dramatically in 2016: During the year ended December of 2016, sales at Geron were $6.16 million. This is a sharp decrease of 83.1% versus 2015, when the company's sales were $36.37 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Geron Corporation
  Stock Performance Chart for Geron Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 1.92
(Figures in U.S. Dollars)
1 Week -5.9%   13 Weeks 3.2%  
4 Weeks -6.3%   52 Weeks -3.5%  
Geron Corporation Key Data:
  Ticker: GERN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 6,162,000
(Year Ending Jan 2017).
Employees: 18
  Currency: U.S. Dollars Market Cap: 305,725,083
  Fiscal Yr Ends: December Shares Outstanding: 159,231,814
  Share Type: Common Closely Held Shares: 835,013
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.